NCT01406548View on ClinicalTrials.gov

Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
OsteopeniaOsteoporosis
Interventions
DRUG

BPS804 20mg/Kg

DRUG

Placebo to 20mg/Kg BPS804

Trial Locations (5)

16635

Novartis Investigative Site, Duncansville

33126

Novartis Investigative Site, Miami

33175

Novartis Investigative Site, Miami

92801-2811

Novartis Investigative Site, Anaheim

08009

Novartis Investigative Site, Berlin

Sponsors

Collaborators (2)

Mereo BioPharma
Novartis
All Listed Sponsors
collaborator

Mereo BioPharma

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

Ultragenyx Pharmaceutical Inc

INDUSTRY

NCT01406548 - Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density | Biotech Hunter | Biotech Hunter